Journal:CHEMBIOINT:2
From Proteopedia
(Difference between revisions)
(39 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | <StructureSection load='' size='450' side='right' scene=' | + | <StructureSection load='' size='450' side='right' scene='81/818590/Cv/16' caption=''> |
===Molecular Dynamics Simulations of the Interaction of Mouse and ''Torpedo'' Acetylcholinesterase with Covalent Inhibitors Explain Their Differential Reactivity: Implications for Drug Design=== | ===Molecular Dynamics Simulations of the Interaction of Mouse and ''Torpedo'' Acetylcholinesterase with Covalent Inhibitors Explain Their Differential Reactivity: Implications for Drug Design=== | ||
- | <big>Nellore Bhanu Chandar, Irena Efremenko, Israel Silman, Jan M.L. Martin, and Joel L. Sussman</big> <ref> | + | <big>Nellore Bhanu Chandar, Irena Efremenko, Israel Silman, Jan M. L. Martin, and Joel L. Sussman</big> <ref>doi https://doi.org/10.1016/j.cbi.2019.06.028</ref> |
<hr/> | <hr/> | ||
<b>Molecular Tour</b><br> | <b>Molecular Tour</b><br> | ||
- | Although the three-dimensional structures of mouse and Torpedo californica | + | Although the <scene name='81/818590/Cv/2'>three-dimensional structures of mouse and Torpedo californica acetylcholinesterase are very similar</scene> (''Tc''AChE ([[1ea5]]) in blue, and mAChE ([[5dti]]) in orange), their responses to the covalent sulfonylating agents benzenesulfonyl fluoride and phenylmethylsulfonyl fluoride are qualitatively different. Both agents inhibit the mouse enzyme effectively by covalent modification of its active site serine. In contrast, whereas the ''Torpedo'' enzyme is effectively inhibited by benzenesulfonyl fluoride, it is almost completely resistant to phenylmethylsulfonyl fluoride. A bottleneck midway down the active-site gorge in both enzymes restricts access of ligands to the active site at the bottom of the gorge. Molecular dynamics simulations revealed that the mouse enzyme is substantially more flexible than the ''Torpedo'' enzyme, suggesting that enhanced ‘breathing motions’ of the mouse enzyme relative to the ''Torpedo'' enzyme may explain why phenylmethylsulfonyl fluoride can reach the active site in mouse acetylcholinesterase, but not in the ''Torpedo'' enzyme. Accordingly, we performed docking of the two sulfonylating agents to the two enzymes, followed by molecular dynamics simulations. Whereas benzenesulfonyl fluoride closely approaches the active-site serine in both mouse and ''Torpedo'' acetylcholinesterase in such simulations, phenylmethylsulfonyl fluoride is able to approach the active-site serine of mouse acetylcholinesterase, but remains trapped above the bottleneck in the ''Torpedo'' enzyme. Our studies demonstrate that reliance on docking tools in drug design can produce misleading information. Docking studies should, therefore, also be complemented by molecular dynamics simulations in selection of lead compounds. |
- | acetylcholinesterase are very similar, their responses to the covalent sulfonylating agents | + | |
- | benzenesulfonyl fluoride and phenylmethylsulfonyl fluoride are qualitatively different. | + | GlideXP docking and MD simulation for interaction of BSF and PMSF with ''Tc''AChE and mAChE. In all four scenes two copies of the ligand are displayed. One shows the position of the ligand after docking alone (blue), and the other shows the position after docking followed by MD simulation (orange). It should be noted that the orientations of the amino-acid side-chains displayed are those seen prior to the MD simulations. |
- | Both agents inhibit the mouse enzyme effectively by covalent modification of its active | + | *<scene name='81/818590/Cv/26'>GlideXP docking and MD simulation for interaction of BSF with TcAChE</scene>. <scene name='81/818590/Cv/22'>Animation of this scene</scene>. |
- | site serine. In contrast, whereas the Torpedo enzyme is effectively inhibited by | + | <jmol><jmolButton> |
- | benzenesulfonyl fluoride, it is almost completely resistant to phenylmethylsulfonyl | + | <script>if (_animating); anim pause;set echo bottom left; color echo white; font echo 20 sansserif;echo Animation Paused; else; anim resume; set echo off;endif;</script> |
- | fluoride. A bottleneck midway down the active-site gorge in both enzymes restricts access | + | <text>Pause/Start Animation</text> |
- | of ligands to the active site at the bottom of the gorge. Molecular dynamics simulations | + | </jmolButton></jmol> |
- | revealed that the mouse enzyme is substantially more flexible than the Torpedo enzyme, | + | *<scene name='81/818590/Cv/30'>GlideXP docking and MD simulation for interaction of BSF with mAChE</scene>. <scene name='81/818590/Cv/29'>Animation of this scene</scene>. |
- | suggesting that enhanced ‘breathing motions’ of the mouse enzyme relative to the Torpedo | + | <jmol><jmolButton> |
- | enzyme may explain why phenylmethylsulfonyl fluoride can reach the active site in mouse | + | <script>if (_animating); anim pause;set echo bottom left; color echo white; font echo 20 sansserif;echo Animation Paused; else; anim resume; set echo off;endif;</script> |
- | acetylcholinesterase, but not in the Torpedo enzyme. Accordingly, we performed docking | + | <text>Pause/Start Animation</text> |
- | of the two sulfonylating agents to the two enzymes, followed by molecular dynamics | + | </jmolButton></jmol> |
- | simulations. Whereas benzenesulfonyl fluoride closely approaches the active-site serine in | + | *<scene name='81/818590/Cv/38'>GlideXP docking and MD simulation for interaction of PMSF with TcAChE</scene>. <scene name='81/818590/Cv/37'>Animation of this scene</scene>. |
- | both mouse and Torpedo acetylcholinesterase in such simulations, phenylmethylsulfonyl | + | <jmol><jmolButton> |
- | fluoride is able to approach the active-site serine of mouse acetylcholinesterase, but | + | <script>if (_animating); anim pause;set echo bottom left; color echo white; font echo 20 sansserif;echo Animation Paused; else; anim resume; set echo off;endif;</script> |
- | remains trapped above the bottleneck in the Torpedo enzyme. Our studies demonstrate that | + | <text>Pause/Start Animation</text> |
- | reliance on docking tools in drug design can produce misleading information. Docking | + | </jmolButton></jmol> |
- | studies should, therefore, also be complemented by molecular dynamics simulations in | + | *<scene name='81/818590/Cv/40'>GlideXP docking and MD simulation for interaction of PMSF with mAChE</scene>. <scene name='81/818590/Cv/39'>Animation of this scene</scene>. |
- | selection of lead compounds. | + | <jmol><jmolButton> |
+ | <script>if (_animating); anim pause;set echo bottom left; color echo white; font echo 20 sansserif;echo Animation Paused; else; anim resume; set echo off;endif;</script> | ||
+ | <text>Pause/Start Animation</text> | ||
+ | </jmolButton></jmol> | ||
<b>References</b><br> | <b>References</b><br> |
Current revision
|
This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.